Octreotide
- PDF / 140,699 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 21 Downloads / 143 Views
1
Octreotide Diarrhoea: case report A 55-year-old man with thyroid stimulating hormonesecreting pituitary adenoma began treatment with IM octreotide [Sandostatin LAR] 30mg monthly and developed diarrhoea [time to reaction onset and outcome not stated]. He underwent adenomectomy and then remained asymptomatic, with normalisation of his free thyroid hormone levels. Author comment: "Octreotide is an effective but expensive therapy and may be associated with adverse effects." Gehmacher U, et al. Thyroid stimulating hormone-secreting pituitary adenoma: A rare, diagnostically challenging, and potentially curable disease. Austrian Journal of Clinical Endocrinology and Metabolism 3: 10, 2010 [abstract] 803076908 Austria
0114-9954/10/1420-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
Reactions 22 Sep 2012 No. 1420
Data Loading...
